Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-31 @ 5:35 PM
Study NCT ID:
NCT01323634
Status:
COMPLETED
Last Update Posted:
2017-11-08
First Post:
2011-03-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-03-18
Start Date Type:
ACTUAL
Primary Completion Date:
2011-12-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-12-14
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-17
First Submit QC Date:
None
Study First Post Date:
2011-03-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-05-30
Results First Submit QC Date:
None
Results First Post Date:
2013-07-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-06-18
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-10-09
Last Update Post Date:
2017-11-08
Last Update Post Date Type:
ACTUAL